Back
Eli Lilly & Co. 10K Form
Buy
54
LLY
Eli Lilly & Co.
Last Price:
$1,003.91
Seasonality Move:
3.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LLY News And Ratings
See the #1 stock for the next 7 days that we like better than LLY
LLY Financial Statistics
Sales & Book Value
| Annual Sales: | $65.2B |
|---|---|
| Cash Flow: | $254.2M |
| Price / Cash Flow: | 153.93 |
| Annual Sales: | $28.09 |
| Price / Book: | 35.83 |
Profitability
| EPS (TTM): | 22.58940 |
|---|---|
| Net Income (TTM): | $20.6B |
| Gross Margin: | $54.1B |
| Return on Equity: | 104.39% |
| Return on Assets: | 20.79% |
Eli Lilly & Co. Earnings Forecast
Key Eli Lilly & Co. Financial Ratios
-
The Gross Profit Margin over the past 46 years for LLY is 83.04%.
-
The Selling, General & Administrative Expenses for LLY have been equal to 17.02% of Gross Profit Margin.
-
The Research & Development expenses have been 20.46% of Revenue.
-
The Interest Expense is 3.11% of Operating Income.
-
The Net Earning history of LLY is 31.67% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 24 years.
Eli Lilly & Co. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LLY |
| CUSIP: | 532457 |
| Website: | lilly.com |
Debt
| Debt-to-Equity Ratio: | 1.65 |
|---|---|
| Current Ratio: | 1.58 |
| Quick Ratio: | 0.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 43.91 |
|---|---|
| Forward P/E Ratio: | 24.02 |
LLY Technical Analysis vs Fundamental Analysis
Buy
54
Eli Lilly & Co. (LLY)
is a Buy
Is Eli Lilly & Co. a Buy or a Sell?
-
Eli Lilly & Co. stock is rated a BuyThe current Eli Lilly & Co. [LLY] share price is $1,007.73. The Score for LLY is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.